Modulation of metabolic, inflammatory, fibrotic and cell death pathways by Resmetirom in metabolic dysfunction-associated steatohepatitis (MASH): A transcriptomic profiling study
Chenyang He, Zheng Wang, Jian-ping Weng, Hans Strijdom, Suo-wen Xu
This study uses transcriptomic profiling to show Resmetirom improves lipid profiles, reduces inflammation and fibrosis, and modulates metabolic and cell death pathways in a MASH mouse model.
Acta Pharmacologica Sinica · Feb 19, 2026Peer-reviewedPharmacology & Toxicology